Skip to content
2000
Volume 22, Issue 3
  • ISSN: 1567-2026
  • E-ISSN: 1875-5739

Abstract

Introduction

This study investigated the neuroprotective mechanisms of ischemic postconditioning (IPostC) in ischemic stroke, focusing on ferroptosis and the regulatory role of the ferroptosis-related gene NADPH oxidase 4 (NOX4).

Methods

Male C57BL/6 mice underwent 45-minute middle cerebral artery occlusion (MCAO), followed by IPostC (three 15s/30s ischemia/reperfusion cycles after initial 2-minute reperfusion). RNA sequencing, combined with the least absolute shrinkage and selection operator (LASSO) and random forest machine learning, quantitative real-time PCR (qRT-PCR), infarct size measurement, and neurological tests, was used to identify ferroptosis-related genes and validate their roles in IPostC-induced neuroprotection.

Results

RNA sequencing revealed that 42 ferroptosis-associated differentially expressed genes underlie the neuroprotective effects of IPostC. Among them, NOX4 emerged as a central pathogenic regulator through LASSO and random forest machine learning analyses. IPostC reduced cerebral infarct size and improved foot-fault rate compared to MCAO mice. Notably, the ferroptosis inducer Erastin abolished the protective effects of IPostC. qRT-PCR validation revealed that IPostC downregulated NOX4 mRNA expression compared to MCAO controls, while Erastin upregulated NOX4 expression. In addition, pharmacological inhibition of NOX4 with GLX351322 reduced its mRNA expression, decreased infarct size, and improved neurological function, further confirming its critical role in mediating ferroptosis-driven brain injury after ischemic stroke.

Discussion

The inhibition of ferroptosis-associated gene NOX4 by IPostC may be a novel mechanism for treating ischemic stroke.

Conclusion

Our study indicates that IPostC attenuates cerebral ischemic injury by suppressing ferroptosis-associated gene NOX4.

© 2025 Bentham Science Publishers
Loading

Article metrics loading...

/content/journals/cnr/10.2174/0115672026416419250930064544
2025-10-06
2026-03-01

  • From This Site

    /content/journals/cnr/10.2174/0115672026416419250930064544
    dcterms_title,dcterms_subject,pub_keyword
    -contentType:Contributor -contentType:Concept -contentType:Institution
    10
    5
Loading full text...

Full text loading...

References

  1. ZhaoY. ZhangX. ChenX. WeiY. Neuronal injuries in cerebral infarction and ischemic stroke: From mechanisms to treatment (Review).Int. J. Mol. Med.20214921510.3892/ijmm.2021.5070 34878154
     [Google Scholar]
  2. QinC. YangS. ChuY.H. Signaling pathways involved in ischemic stroke: Molecular mechanisms and therapeutic interventions.Signal Transduct. Target. Ther.20227121510.1038/s41392‑022‑01064‑1 35794095
     [Google Scholar]
  3. ArkeliusK. WendtT.S. AnderssonH. LOX-1 and MMP-9 inhibition attenuates the detrimental effects of delayed rt-PA therapy and improves outcomes after acute ischemic stroke.Circ. Res.2024134895496910.1161/CIRCRESAHA.123.323371 38501247
     [Google Scholar]
  4. ZhangY. ChenQ. ChenD. SerpinA3N attenuates ischemic stroke injury by reducing apoptosis and neuroinflammation.CNS Neurosci. Ther.202228456657910.1111/cns.13776 34897996
     [Google Scholar]
  5. ZhaoM. QiaoY. WeissA. ZhaoW. Neuroprotective strategies in acute ischemic stroke: A narrative review of recent advances and clinical outcomes.Brain Circ.202410429630210.4103/bc.bc_165_24 40012592
     [Google Scholar]
  6. ChengZ. WangH. GengX. Time and tissue windows in futile reperfusion after ischemic stroke.Aging Dis.20241652544255210.14336/AD.2024.1024 39500359
     [Google Scholar]
  7. BergeE. WhiteleyW. AudebertH. European Stroke Organisation (ESO) guidelines on intravenous thrombolysis for acute ischaemic stroke.Eur. Stroke J.202161ILXII10.1177/2396987321989865 33817340
     [Google Scholar]
  8. SuzukiK. MatsumaruY. TakeuchiM. Effect of mechanical thrombectomy without vs with intravenous thrombolysis on functional outcome among patients with acute ischemic stroke.JAMA2021325324425310.1001/jama.2020.23522 33464334
     [Google Scholar]
  9. TianB. TianX. ShiZ. Clinical and imaging indicators of hemorrhagic transformation in acute ischemic stroke after endovascular thrombectomy.Stroke20225351674168110.1161/STROKEAHA.121.035425 34872341
     [Google Scholar]
  10. ZubairA.S. ShethK.N. Hemorrhagic conversion of acute ischemic stroke.Neurotherapeutics202320370571110.1007/s13311‑023‑01377‑1 37085684
     [Google Scholar]
  11. QiaoY. FayyazA.I. DingY. JiX. ZhaoW. Recent advances in the prevention of secondary ischemic stroke: A narrative review.Brain Circ.202410428329510.4103/bc.bc_159_24 40012589
     [Google Scholar]
  12. AlsbrookD.L. Di NapoliM. BhatiaK. Neuroinflammation in acute ischemic and hemorrhagic stroke.Curr. Neurol. Neurosci. Rep.202323840743110.1007/s11910‑023‑01282‑2 37395873
     [Google Scholar]
  13. GuanX. ZhuS. SongJ. Microglial CMPK2 promotes neuroinflammation and brain injury after ischemic stroke.Cell Rep. Med.20245510152210.1016/j.xcrm.2024.101522 38701781
     [Google Scholar]
  14. ShenZ. XiangM. ChenC. Glutamate excitotoxicity: Potential therapeutic target for ischemic stroke.Biomed. Pharmacother.202215111312510.1016/j.biopha.2022.113125 35609367
     [Google Scholar]
  15. NevesD. SalazarI.L. AlmeidaR.D. SilvaR.M. Molecular mechanisms of ischemia and glutamate excitotoxicity.Life Sci.202332812181410.1016/j.lfs.2023.121814 37236602
     [Google Scholar]
  16. CoppiE. CherchiF. GibbA.J. Adenosine A2A receptor blockade attenuates excitotoxicity in rat striatal medium spiny neurons during an ischemic-like insult.Neural Regen. Res.202419225525710.4103/1673‑5374.375309 37488874
     [Google Scholar]
  17. GuoP. LiH. ZhangX. Matrix metalloproteinase 9 in hemorrhagic transformation after acute ischemic stroke (Review).Mol. Med. Rep.202532211510.3892/mmr.2025.13590 40476578
     [Google Scholar]
  18. LuW. WenJ. The relationship among H2S, neuroinflammation and MMP-9 in BBB injury following ischemic stroke.Int. Immunopharmacol.202514611390210.1016/j.intimp.2024.113902 39724730
     [Google Scholar]
  19. UgaleR. VatteS. GirdharP. AnandaniD. Deferoxamine prevents BBB disruption, neuroinflammation and apoptotic changes in early hours of ischemic reperfusion injury.Neurochem. Int.202518810600910.1016/j.neuint.2025.106009 40517956
     [Google Scholar]
  20. WangA-P. TianY. ZhangW. Microglia-associated neuroinflammation is a potential therapeutic target for ischemic stroke.Neural Regen. Res.202116161110.4103/1673‑5374.286954 32788440
     [Google Scholar]
  21. LiangZ. LouY. HaoY. LiH. FengJ. LiuS. The relationship of astrocytes and microglia with different stages of ischemic stroke.Curr. Neuropharmacol.202321122465248010.2174/1570159X21666230718104634 37464832
     [Google Scholar]
  22. PiccaA. CalvaniR. Coelho-JuniorH.J. LandiF. BernabeiR. MarzettiE. Mitochondrial dysfunction, oxidative stress, and neuroinflammation: Intertwined roads to neurodegeneration.Antioxidants20209864710.3390/antiox9080647 32707949
     [Google Scholar]
  23. XuX. PangY. FanX. Mitochondria in oxidative stress, inflammation and aging: From mechanisms to therapeutic advances.Signal Transduct. Target. Ther.202510119010.1038/s41392‑025‑02253‑4 40500258
     [Google Scholar]
  24. JiangR.Q. LiQ.Q. ShengR. Mitochondria associated ER membranes and cerebral ischemia: Molecular mechanisms and therapeutic strategies.Pharmacol. Res.202319110676110.1016/j.phrs.2023.106761 37028777
     [Google Scholar]
  25. ZhangY. ZhangH. ZhaoF. Mitochondrial-targeted and ROS-responsive nanocarrier via nose-to-brain pathway for ischemic stroke treatment.Acta Pharm. Sin. B202313125107512010.1016/j.apsb.2023.06.011 38045064
     [Google Scholar]
  26. WangJ. YangL. WuL. Direct ischemic postconditioning following stroke thrombectomy: A promising therapy for reperfusion injury.Neurosci. Bull.20244071017102010.1007/s12264‑024‑01243‑w 38856959
     [Google Scholar]
  27. MohammadiM. MobiniM. MashayekhiF. Ischemic post-conditioning is neuroprotective even at delayed tPA administration after embolic stroke in female rats.Iran. J. Basic Med. Sci.202124121676168210.22038/IJBMS.2021.55674.12456 35432799
     [Google Scholar]
  28. DengJ. HeG. YiT. Neuroprotective effects of rapid local ischemic postconditioning in successful endovascular thrombectomy patients.Stroke202455122896290010.1161/STROKEAHA.124.047674 39523943
     [Google Scholar]
  29. WuL. WeiM. ZhangB. Safety and tolerability of direct ischemic postconditioning following thrombectomy for acute ischemic stroke.Stroke20235492442244510.1161/STROKEAHA.123.044060 37497674
     [Google Scholar]
  30. MorisakiY. NakagawaI. OgawaY. Ischemic postconditioning reduces NMDA receptor currents through the opening of the mitochondrial permeability transition pore and KATP channel in mouse neurons.Cell. Mol. Neurobiol.20224241079108910.1007/s10571‑020‑00996‑y 33159622
     [Google Scholar]
  31. SasakiH. NakagawaI. FurutaT. Mitochondrial calcium uniporter (MCU) is involved in an ischemic postconditioning effect against ischemic reperfusion brain injury in mice.Cell. Mol. Neurobiol.20244413210.1007/s10571‑024‑01464‑7 38568450
     [Google Scholar]
  32. ChenH. ShenJ. ZhaoH. Ischemic postconditioning for stroke treatment: Current experimental advances and future directions.Cond. Med.202032104115 34396060
     [Google Scholar]
  33. LiuZ. HuangW. ChenY. Ischemic postconditioning ameliorates acute kidney injury induced by limb ischemia/reperfusion via transforming TLR4 and NF-κB signaling in rats.J. Orthop. Surg. Res.202116141610.1186/s13018‑021‑02565‑5 34210334
     [Google Scholar]
  34. MiaoW. YanY. BaoT. Ischemic postconditioning exerts neuroprotective effect through negatively regulating PI3K/Akt2 signaling pathway by microRNA-124.Biomed. Pharmacother.202012610978610.1016/j.biopha.2019.109786 32113052
     [Google Scholar]
  35. YuY. YanY. NiuF. Ferroptosis: A cell death connecting oxidative stress, inflammation and cardiovascular diseases.Cell Death Discov.20217119310.1038/s41420‑021‑00579‑w 34312370
     [Google Scholar]
  36. LiuJ. KangR. TangD. Signaling pathways and defense mechanisms of ferroptosis.FEBS J.2022289227038705010.1111/febs.16059 34092035
     [Google Scholar]
  37. JiangX. StockwellB.R. ConradM. Ferroptosis: Mechanisms, biology and role in disease.Nat. Rev. Mol. Cell Biol.202122426628210.1038/s41580‑020‑00324‑8 33495651
     [Google Scholar]
  38. TangD. ChenX. KangR. KroemerG. Ferroptosis: Molecular mechanisms and health implications.Cell Res.202131210712510.1038/s41422‑020‑00441‑1 33268902
     [Google Scholar]
  39. ChenX. KangR. KroemerG. TangD. Organelle-specific regulation of ferroptosis.Cell Death Differ.202128102843285610.1038/s41418‑021‑00859‑z 34465893
     [Google Scholar]
  40. HuX. BaoY. LiM. ZhangW. ChenC. The role of ferroptosis and its mechanism in ischemic stroke.Exp. Neurol.202437211463010.1016/j.expneurol.2023.114630 38056585
     [Google Scholar]
  41. GuoJ. TuoQ. LeiP. Iron, ferroptosis, and ischemic stroke.J. Neurochem.2023165448752010.1111/jnc.15807 36908209
     [Google Scholar]
  42. LiaoJ. WeiM. WangJ. Naotaifang formula attenuates OGD/R-induced inflammation and ferroptosis by regulating microglial M1/M2 polarization through BMP6/SMADs signaling pathway.Biomed. Pharmacother.202316711546510.1016/j.biopha.2023.115465 37713988
     [Google Scholar]
  43. ChenH. HeY. ChenS. QiS. ShenJ. Therapeutic targets of oxidative/nitrosative stress and neuroinflammation in ischemic stroke: Applications for natural product efficacy with omics and systemic biology.Pharmacol. Res.202015810487710.1016/j.phrs.2020.104877 32407958
     [Google Scholar]
  44. LiuC. YangJ. ZhangC. GengX. ZhaoH. Remote ischemic conditioning reduced cerebral ischemic injury by modulating inflammatory responses and ERK activity in type 2 diabetic mice.Neurochem. Int.202013510469010.1016/j.neuint.2020.104690 31981607
     [Google Scholar]
  45. YaoY. LiY. NiW. Systematic study of immune cell diversity in ischemic postconditioning using high-dimensional single-cell analysis with mass cytometry.Aging Dis.202112381282510.14336/AD.2020.1115 34094644
     [Google Scholar]
  46. RenH. ZhangZ. ZhangJ. Physical exercise exerts neuroprotective effect on memory impairment by mitigate the decline of] striatum catecholamine and spine density in a vascular dementia] rat model.Am. J. Alzheimers Dis. Other Demen.2022371533317522114436710.1177/15333175221144367 36515911
     [Google Scholar]
  47. ChenC. ChenchengZ. CuiyingL. XiaokunG. Plasmacytoid dendritic cells protect against middle cerebral artery occlusion induced brain injury by priming regulatory T cells.Front. Cell. Neurosci.202014810.3389/fncel.2020.00008 32076400
     [Google Scholar]
  48. LuoE. LiZ. ZhangS. Hyperglycemia induces microglial pyroptosis by increasing oxygen extraction rate: Implication in neurological impairment during ischemic stroke.Mol. Med. Rep.202430214610.3892/mmr.2024.13270 38940333
     [Google Scholar]
  49. WangY. ZhuangH. JiangX. ZouR. WangH. FanZ. Unveiling the key genes, environmental toxins, and drug exposures in modulating the severity of ulcerative colitis: A comprehensive analysis.Front. Immunol.202314116245810.3389/fimmu.2023.1162458 37539055
     [Google Scholar]
  50. MaQ. WangC. WangM. Investigation of brain damage mechanism in middle cerebral artery occlusion/reperfusion rats based on i-TRAQ quantitative proteomics.Exp. Brain Res.202123941247126010.1007/s00221‑021‑06054‑3 33599834
     [Google Scholar]
  51. YuG. WangL.G. HanY. HeQ.Y. clusterProfiler: An R package for comparing biological themes among gene clusters.OMICS201216528428710.1089/omi.2011.0118 22455463
     [Google Scholar]
  52. ZhangN. WangY. WangJ. Transcriptomic analysis of regulatory mechanisms in the telogen-anagen transition of ovine hair follicles.BMC Genomics2024251116610.1186/s12864‑024‑11059‑7 39623320
     [Google Scholar]
  53. BernhardtA. JamilA. MorshedM.T. Oxidative stress and regulation of adipogenic differentiation capacity by sirtuins in adipose stem cells derived from female patients of advancing age.Sci. Rep.20241411988510.1038/s41598‑024‑70382‑x 39191852
     [Google Scholar]
  54. GeraceE. ScartabelliT. Pellegrini-GiampietroD.E. LanducciE. Tolerance induced by (S)-3,5-Dihydroxyphenylglycine postconditioning is mediated by the PI3K/Akt/GSK3β signalling pathway in an in vitro model of cerebral ischemia.Neuroscience202043322122910.1016/j.neuroscience.2019.12.047 31935492
     [Google Scholar]
  55. SisalliM.J. SecondoA. EspositoA. Endoplasmic reticulum refilling and mitochondrial calcium extrusion promoted in neurons by NCX1 and NCX3 in ischemic preconditioning are determinant for neuroprotection.Cell Death Differ.20142171142114910.1038/cdd.2014.32 24632945
     [Google Scholar]
  56. FormisanoL. GuidaN. MascoloL. Transcriptional and epigenetic regulation of ncx1 and ncx3 in the brain.Cell Calcium20208710219410.1016/j.ceca.2020.102194 32172011
     [Google Scholar]
  57. FormisanoL. LaudatiG. GuidaN. HDAC4 and HDAC5 form a complex with DREAM that epigenetically down-regulates NCX3 gene and its pharmacological inhibition reduces neuronal stroke damage.J. Cereb. Blood Flow Metab.202040102081209710.1177/0271678X19884742 31696766
     [Google Scholar]
  58. PignataroG. CuomoO. VinciguerraA. NCX as a key player in the neuroprotection exerted by ischemic preconditioning and postconditioning.Adv. Exp. Med. Biol.201396122324010.1007/978‑1‑4614‑4756‑6_19 23224883
     [Google Scholar]
  59. PignataroG. EspositoE. CuomoO. The NCX3 isoform of the Na+/Ca2+ exchanger contributes to neuroprotection elicited by ischemic postconditioning.J. Cereb. Blood Flow Metab.201131136237010.1038/jcbfm.2010.100 20628398
     [Google Scholar]
  60. WeiD. XiongX. ZhaoH. Tim-3 cell signaling and iNOS are involved in the protective effects of ischemic postconditioning against focal ischemia in rats.Metab. Brain Dis.201530248349010.1007/s11011‑014‑9543‑2 24771108
     [Google Scholar]
  61. DriggersC.M. ShyngS.L. Mechanistic insights on KATP channel regulation from cryo-EM structures.J. Gen. Physiol.2023155120211304610.1085/jgp.202113046 36441147
     [Google Scholar]
  62. LiuC. GuanT. LaiY. ShenY. Association of KATP gene polymorphisms with dyslipidemia and ischemic stroke risks among hypertensive patients in South China.J. Mol. Neurosci.202171102142215110.1007/s12031‑020‑01761‑y 33400071
     [Google Scholar]
  63. ZhaoC. FuX. YangZ. ZhangQ. ZhaoY. ATP-sensitive potassium channel opener, Nicorandil, inhibits NF-κB/AIM2/GSDMD pathway activation to protect against neuroinflammation in ischemic stroke.Neurochem. Int.202417910581010.1016/j.neuint.2024.105810 39069080
     [Google Scholar]
  64. ZhaoY. YangZ. HeY. SunR. YuanH. The KATP channel opener, nicorandil, ameliorates brain damage by modulating synaptogenesis after ischemic stroke.PLoS One2021161024601910.1371/journal.pone.0246019 33497397
     [Google Scholar]
  65. FuJ. MuG. LiuX. OuC. ZhaoJ. Ischemic postconditioning reduces spinal cord ischemia-reperfusion injury through ATP-sensitive potassium channel.Spinal Cord202260432633110.1038/s41393‑021‑00714‑5 34616009
     [Google Scholar]
  66. LiJ. ZhouW. ChenW. WangH. ZhangY. YuT. Mechanism of the hypoxia inducible factor 1/hypoxic response element pathway in rat myocardial ischemia/diazoxide post conditioning.Mol. Med. Rep.20202131527153610.3892/mmr.2020.10966 32016463
     [Google Scholar]
  67. XuY. LiK. ZhaoY. ZhouL. LiuY. ZhaoJ. Role of Ferroptosis in Stroke.Cell. Mol. Neurobiol.202343120522210.1007/s10571‑022‑01196‑6 35102454
     [Google Scholar]
  68. YangK. ZengL. YuanX. The mechanism of ferroptosis regulating oxidative stress in ischemic stroke and the regulation mechanism of natural pharmacological active components.Biomed. Pharmacother.202215411361110.1016/j.biopha.2022.113611 36081288
     [Google Scholar]
  69. ParkM.W. ChaH.W. KimJ. NOX4 promotes ferroptosis of astrocytes by oxidative stress-induced lipid peroxidation via the impairment of mitochondrial metabolism in Alzheimer’s diseases.Redox Biol.20214110194710.1016/j.redox.2021.101947 33774476
     [Google Scholar]
  70. VermotA. Petit-HärtleinI. SmithS.M.E. FieschiF. NADPH Oxidases (NOX): An overview from discovery, molecular mechanisms to physiology and pathology.Antioxidants202110689010.3390/antiox10060890 34205998
     [Google Scholar]
  71. LiG. YeC. ZhuY. Oxidative injury in ischemic stroke: A focus on NADPH oxidase 4.Oxid. Med. Cell. Longev.202220221114887410.1155/2022/1148874 35154560
     [Google Scholar]
  72. BoonpramanN. YoonS. KimC.Y. MoonJ.S. YiS.S. NOX4 as a critical effector mediating neuroinflammatory cytokines, myeloperoxidase and osteopontin, specifically in astrocytes in the hippocampus in Parkinson’s disease.Redox Biol.20236210269810.1016/j.redox.2023.102698 37058998
     [Google Scholar]
  73. GolaL. BierhanslL. CsatáriJ. NOX4-derived ROS are neuroprotective by balancing intracellular calcium stores.Cell. Mol. Life Sci.202380512710.1007/s00018‑023‑04758‑z 37081190
     [Google Scholar]
  74. QuY. SunY. YangZ. DingC. Calcium ions signaling: Targets for attack and utilization by viruses.Front. Microbiol.20221388937410.3389/fmicb.2022.889374 35859744
     [Google Scholar]
  75. WangJ. LiuY. ShenH. LiH. WangZ. ChenG. Nox2 and Nox4 participate in ROS-induced neuronal apoptosis and brain injury during ischemia-reperfusion in rats.Acta Neurochir. Suppl.2020127475410.1007/978‑3‑030‑04615‑6_8 31407062
     [Google Scholar]
/content/journals/cnr/10.2174/0115672026416419250930064544
Loading
Ischemic Postconditioning Attenuates Cerebral Ischemic Injury by Suppressing the Ferroptosis-associated Gene NOX4
Curr Neurovasc Res 22, 224 (2025); https://doi.org/10.2174/0115672026416419250930064544
/content/journals/cnr/10.2174/0115672026416419250930064544
/content/journals/cnr/10.2174/0115672026416419250930064544
Loading

Data & Media loading...


  • Article Type:     Research Article
Keyword(s): cerebral ischemic injury; ferroptosis; Ischemic postconditioning; ischemic stroke; NADPH oxidase 4 (NOX4); neuroprotection

Most Cited Most Cited RSS feed

This is a required field
Please enter a valid email address
Approval was a Success
Invalid data
An Error Occurred
Approval was partially successful, following selected items could not be processed due to error
Please enter a valid_number test